Information


Contact Numbers

Microbiology Department UHW: 

Microbiology SpR 

Ext. 8479

Dr. G Chan

Ext. 2621/2097 

Dr. M. Doyle

Ext. 2621/2097 

Dr. V Murphy

Ext. 2621/2097 

Dr. C. Fielding

Ext. 2621/2097 

( Via UHW Switchboard )

 051-848000

Pharmacy Departments.:

UHW Antimicrobial Pharmacist

Bleep 88666 

WGH Antimicrobial Pharmacist 

Ext. 3261

SLKK/Kilcreene Antimicrobial Pharmacist 

Ext. 5372/5328 

STGH Antimicrobial Pharmacist 

Ext. 7119 


Feedback

If you have any questions about the content of this Guidelines app or have feedback for hospital administrators in charge of content you can contact them via the link below.

Uhw.amspharmacist@hse.ie


Developer Feedback

If you have any questions about the content of this Guidelines app or have feedback for hospital administrators in charge of content you can contact them via the link below.

Send Feedback


References

  1. Guidelines for Antimicrobial Stewardship in Hospitals in Ireland. SARI Hospital Antimicrobial Stewardship Working Group. December 2009.

  2. Policy on Control and Prevention of Meticillin Resistant Staphylococcus aureus (MRSA) in Acute Hospitals in the HSE/SE. November 2009.

  3. Gupta K et al International Clinical Practice Guideline for the treatment of acute uncomplicated cystitis and pylenephritis in women. 2010 update by IDSA and ESCMID. CID 2011; 52: 103-120.

  4. Lim WS, Baudouin SV, George RC et al. BTS Guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 Suppl 3: iii1-55.

  5. Brito V et al. Healthcare - associated pneumonia is a heterogenous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Current Opinion in Infectious Diseases 2009; 22: 316-325.

  6. Masterton. RG et al. Guidelines for the management of hospital acquired pneumonia in the UK. JAC 2008; 62: 5-34.

  7. James D. Chalmers, Mudher Al-Khairalla, Philip M. Short, Tom C. Fardon and John H. Winter. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. J Antimicrob Chemother 2010; 65: 608-618.

  8. Policy on Prevention and Control of Clostridium difficile – associated disease In Acute Hospitals HSE/ South East. January 2010.

  9. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer, 2010 update by the IDSA. CID 2011; 52(4): e56-e93.

  10. Davey et al. Interventions to improve antibiotic prescribing practices for hospital inpatients (review). The Cochrane Library Oct 2008.

  11. Royal College of Obstretricians Green top guideline no 64A Bacterial Sepsis in Pregnancy.

  12. HSE Adult Patient Observation Chart.

  13. Surveillance, Diagnosis and Management of Clostridium difficile Infection in Ireland Update of 2008

    Guidance HPSC 2013

  14. Sepsis Management. National Clinical Guideline No.6. National Clinical Effectiveness Committee, Nov. 201

  15. BNF 59 March – September 2015

  16. Gilbert N, Chambers F, Eliopoulos G et al Sanford Guide to Antimicrobial Therapy 2014 44th Edition

  17. Ashley C, Dunleavy A. The Renal Handbook 4th Edition 2014

  18. Amikacin Product SPC accessed online 29th May 2015 on www.medicines.ie

  19. Ali MZ & Goetz MB: A meta analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24;

  20. UpToDate, www.uptodate.com

  21. Summary of Product Characteristics (SPC)

  22. Guidelines for the Prevention and Control of Multi-drug resistant organisms (MDRO) excluding MRSA in the healthcare setting. Published on behalf of the Royal College of Physicians clinical advisory group on Healthcare Associated infections in association with HSE Quality and Patient Safety

  23. Guidelines for Emergency Management of Injuries. 2012. www.emitoolkit.ie